Skip to main content
Livermore
Livermore
ZHEN

Rathbone Brothers plc

SEC CIK
0001351991
Latest filing
Jul 23, 2026

ADAPY holding history

Adaptimmune Therapeutics PLC in every 13F filed by Rathbone Brothers plc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADAPY overviewAll 13F holders of ADAPYFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of ADAPY by Rathbone Brothers plc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−432,818−100.0%Sold outHolders
Q4 2025432,818$11.3K<0.1%00.0%UnchangedHolders
Q3 2025432,818$56.3K<0.1%00.0%UnchangedHolders
Q2 2025432,818$103.7K<0.1%00.0%UnchangedHolders
Q1 2025432,818$85.3K<0.1%00.0%UnchangedHolders
Q4 2024432,818$233.2K<0.1%00.0%UnchangedHolders
Q3 2024432,818$411.4K<0.1%00.0%UnchangedHolders
Q2 2024432,818$422.0K<0.1%00.0%UnchangedHolders
Q1 2024432,818$683.9K<0.1%00.0%UnchangedHolders
Q4 2023432,818$343.2K<0.1%00.0%UnchangedHolders
Q3 2023432,818$337.6K<0.1%00.0%UnchangedHolders
Q2 2023432,818$400.4K<0.1%00.0%UnchangedHolders
Q1 2023432,818$471.8K<0.1%00.0%UnchangedHolders
Q4 2022432,818$631.9K<0.1%00.0%UnchangedHolders
Q3 2022432,818$465.0K<0.1%00.0%UnchangedHolders
Q2 2022432,818$736.0K<0.1%00.0%UnchangedHolders
Q1 2022432,818$892.0K<0.1%00.0%UnchangedHolders
Q4 2021432,818$1.62M<0.1%−1030.0%ReducedHolders
Q3 2021432,921$2.24M<0.1%00.0%UnchangedHolders
Q2 2021432,921$1.84M<0.1%00.0%UnchangedHolders
Q1 2021432,921$2.30M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.